We transform health

by developing diagnostic self-tests
for infectious diseases
Our technology

INNOVATIVE APPROACH TO DETECTING DISEASE

We produce diagnostic self-tests for deadly infectious diseases. We use deep biotechnology to detect biomarkers in saliva without medical staff and laboratory equipment.

Early detection is the best way to strengthen global efforts in eradicating deadly infectious diseases. We are partnering with leading health research organizations to produce groundbreaking diagnostic products. Our goal is to contain the spread of infectious diseases.

OUR TESTS ARE

Non-invasive
Saliva based self-test
Anonymous
Results via color change
Affordable
Medical staff and laboratory not required

WITH A FOCUS ON

Turberculosis
Hepatitis B
COVID-19
Technology

A  SYMBIOSIS OF TALENTS

Our team of experienced scientists and business experts is specialized in infectious diseases, clinical diagnostics and bioorganic chemistry. We are in R&D stage developing a diagnostic biotechnology platform for infectious diseases that can reduce testing costs by 80%.

We are headquartered in Denmark, one of the leading biotech hubs in the world, with development partners in Brazil and Germany.

Our team

LATEST NEWS

€140.000 Innobooster granted
Partnership with Rigshospitalet
Dianox CEO meets President Obama
We continuously share insights on our recent developments.
€140.000 Innobooster granted
Partnership with Rigshospitalet
Dianox CEO meets President Obama
More news

WITH YOUR HELP WE CAN CHANGE THE WORLD

Would you like to know more about our technology and its applications?
Contact us